ODTX

Odyssey Therapeutics, Inc.

There isn't enough reported data to score ODTX yet.

ODTX Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate ODTX's fundamentals.

ODTX PE Valuation

ODTX has no meaningful PE right now: it lost money over the past year.

ODTX Forward outlook

There aren't enough analyst estimates for ODTX to show an outlook.

ODTX Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $20.10 on Nov 12.

There is not enough scenario data to assess ODTX's risk to reward.

ODTX Earnings Per Share

ODTX Quarterly Revenue

Q1 2026: $0Q2 2026: $0Q3 2026: $0
Q1 2026: $0Q2 2026: $0Q3 2026: $0

ODTX Free Cash Flow

Q1 2026: โˆ’$41MQ2 2026: โˆ’$35MQ3 2026: โˆ’$42M
Q1 2026: โˆ’$41MQ2 2026: โˆ’$35MQ3 2026: โˆ’$42M

ODTX Total Shares

Q1 2026: 6MQ2 2026: 30MQ3 2026: 48M
Q1 2026: 6MQ2 2026: 30MQ3 2026: 48M
PeriodChange %Net change
Quarterly+59%+17.7M shares

ODTX Net Leverage

ODTX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ODTX Weekly Momentum

MetricValueStatus
RSI56.0Neutral
Stochastic25.7Neutral

ODTX's weekly RSI is 56 (neutral) and its Stochastic is 26 (neutral).

ODTX PE vs Healthcare Sector

ODTX has no meaningful PE right now: it lost money over the past year.

ODTX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$19.53.2% above
20 week MA$20.83.1% below

ODTX has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 3.1% below its 20-week average.

ODTX Yearly ROI

YearStart priceEnd priceROI
2026 YTD$16.4$20.1+22%

It's up 22% so far in 2026.

Give your agent the market.

Get API key